. 2013 Jan 30;11(2):350–362. doi: 10.3390/md11020350

Table 3.

Effects of HPN on serum lipid in db/db mice.

Group	Dose (mg/kg)	Triglycerides (mmol/L) ^a
Group	Dose (mg/kg)	Baseline	4 weeks	8 weeks	Baseline	4 weeks	8 weeks
Control		1.19 ± 0.25	1.30 ± 0.26	1.19 ± 0.24	3.01 ± 0.83	3.32 ± 0.80	2.99 ± 0.72
Model		1.47 ± 0.30 *	1.69 ± 0.39 *	1.74 ± 0.40 **	4.20 ± 1.17 *	7.22 ± 2.91 **	7.18 ± 2.18 **
HPN	40	1.36 ± 0.35	1.32 ± 0.21 ^#	1.32 ± 0.34 ^#	3.89 ± 0.93	4.67 ± 1.55 ^#	5.01 ± 1.64 ^#
	20	1.44 ± 0.42	1.32 ± 0.27 ^#	1.36 ± 0.31 ^#	3.86 ± 1.42	5.01 ± 1.45	5.12 ± 2.31
	10	1.44 ± 0.28	1.45 ± 0.30	1.47 ± 0.32	4.72 ± 0.91	5.54 ± 1.59	5.79 ± 1.69
Rosiglitazone	20	1.46 ± 0.23	1.33 ± 0.27 ^#	1.36 ± 0.23 ^#	4.19 ± 1.04	4.67 ± 1.42 ^#	4.44 ± 1.60 ^##

^a Data are expressed as means ± SD, n = 10; ^# P < 0.05, ^## P < 0.01 when compared to the model group; ** P < 0.01 when compared to the control group.